Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis.
(2011) Rheumatology (Print) —
Files
No attached file found for this publication.
Details
- Authors
- Affiliations
Citations
Smolen, J. S., Boers, M., Abadie, E. C., Breedveld, F. C., Emery, P., Bardin, T., Goel, N., Ethgen, D. J., Avouac, B. P., Durez, P., Flamion, B., Laslop, A., Miossec, P., Reiter, S., & Reginster, J.-Y. (2011). Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis. Rheumatology (Print). https://doi.org/10.1093/rheumatology/keq413